Top Markets
Coin of the day
Pharmosa Biopharm Inc. Pharmosa Biopharm Inc.

Pharmosa Biopharm Inc.

6875
Kedudukan dalam Saham #20403
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Harga Saham
$1.02
Modal Pasaran
$131.45M
Perubahan (1 hari)
-0.62%
Perubahan (1 tahun)
-37.92%
Negara
TW
Perdagangan Pharmosa Biopharm Inc. (6875)

Kategori

Sejarah harga saham bagi Pharmosa Biopharm Inc. (6875)
Harga penutupan tertinggi: $1.04 pada 2026-08-01

Harga penutupan terendah: $1.60 pada 2022-02-01
Sejarah harga saham Pharmosa Biopharm Inc. dari 2022 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -19.43%
2025 1.72%
2024 -40.77%
2023 55.60%
2022 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.27 -15.19%
AU
$764.47 8.17%
CH